Iovance Shares Jump on Rising Demand for Melanoma Cell Therapy
Iovance Biotherapeutics shares surged as strong demand for its melanoma drug drove company growth, signaling the therapy's uptake is outpacing market expectations.
Topic
Industry
Topic
Topic
Topic
Iovance Biotherapeutics shares surged as strong demand for its melanoma drug drove company growth, signaling the therapy's uptake is outpacing market expectations.